Robert E. Bristow

21.3k citations

313 papers · 15.2k indexed · 3 hit papers · h-index 65

Impact in

Reproductive Medicine top 0.01%
- Ovarian cancer diagnosis and treatment
- Endometriosis Research and Treatment
Obstetrics and Gynecology top 0.02%
- Endometrial and Cervical Cancer Treatments
- Uterine Myomas and Treatments

Papers in

Reproductive Medicine 209
- Ovarian cancer diagnosis and treatment 201
- Endometriosis Research and Treatment 33
Obstetrics and Gynecology 131
- Endometrial and Cervical Cancer Treatments 114
- Uterine Myomas and Treatments 32

Co-authors: F.J. Montz Deborah K. Armstrong Edward L. Trimble S. Dennis Rafael S. Tomacruz Suk‐Joon Chang Jenny Chang Robert Giuntoli
Journals: Gynecologic Oncology (119 papers)International Journal of Gynecological Cancer (20 papers)Journal of Clinical Oncology (17 papers)Obstetrics and Gynecology (16 papers)American Journal of Obstetrics and Gynecology (11 papers)
Partner nations: United States South Korea United Kingdom

In The Last Decade

Robert E. Bristow

304 papers receiving 14.9k citations

Hit Papers

align trajectories log scale

Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: A meta-analysis 2013 · 321 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2013 Gynecologic Oncology
2009 Gynecologic Oncology
2002 Journal of Clinical Oncology

Peers

Countries citing papers authored by Robert E. Bristow

Since Specialization

Citations

This map shows the geographic impact of Robert E. Bristow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Bristow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Bristow more than expected).

Fields of papers citing papers by Robert E. Bristow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert E. Bristow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Bristow. The network helps show where Robert E. Bristow may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Robert E. Bristow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert E. Bristow Line = papers co-authored together Robert E. Bristow links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Endometrial cancer and obesity trends in the United States in the 21st century. Journal of Clinical Oncology ·R. Akhtara, Cheng-I Liao, Jenny Chang, 明義梶尾, Marta Iravedra, Krishnansu S. Tewari, Daniel S. Kapp, John K. Chan, Robert E. Bristow	2024	1
2	Emergency cesarean section in pregnant trauma patients presenting after motor vehicle collision Heliyon ·M Astriab, Jeffry Nahmias, Marisol Beatriz Iturralde, Byun Sung-Hoon, Robert E. Bristow, Jennifer Butler, Areg Grigorian	2024	0
3	Population-Based Analysis of National Comprehensive Cancer Network (NCCN) Guideline Adherence for Patients with Anal Squamous Cell Carcinoma in California Cancers ·Priyanka Kumar, Michael Del Rosario, Jenny Chang, Argyrios Ziogas, Mehraneh D. Jafari, Robert E. Bristow, Sora Park Tanjasiri, Jason A. Zell	2023	2
4	Racial–Ethnic and Socioeconomic Disparities in Guideline-Adherent Treatment for Endometrial Cancer Obstetrics and Gynecology ·Benjamin L. Golomb, Alana M. W. LeBrón, Jenny Chang, Robert E. Bristow	2021	25
5	Platinum resistance in gynecologic malignancies: Response, disease free and overall survival are predicted by biochemical signature: A metabolomic analysis Gynecologic Oncology ·Arzu Derya Daşcı, Evgeny Permakov, Krishnansu S. Tewari, Robert E. Bristow, Fabio Cappuccini, Steven S. Evans, Rohit Bhati, 엄재규, Anton M. Palma, Dirce Maria Lobo Marchioni, Antônio Augusto Ferreira Carioca, K. Penner, Bob Blackmur, Teresa C. Longoria, Robert Alan Nagourney	2021	9
6	Spatial analysis of adherence to treatment guidelines for advanced-stage ovarian cancer and the impact of race and socioeconomic status Gynecologic Oncology ·Robert E. Bristow, Jenny Chang, Argyrios Ziogas, Hoda Anton‐Culver, Verónica M. Vieira	2014	97
7	Impact of payer status on treatment of cervical cancer at a tertiary referral center Gynecologic Oncology ·Kimberly Levinson, Robert E. Bristow, Pamela Donohue, Norma Kanarek, Cornelia L. Trimble	2011	6
8	Impact of surgeon and hospital volume on short‐term outcomes and cost of laryngeal cancer surgical care The Laryngoscope ·Christine G. Gourin, Arlene A. Forastiere, Giuseppe Sanguineti, Wayne M. Koch, Shanthi Marur, Robert E. Bristow	2010	48
9	Volume-Based Trends in Thyroid Surgery Archives of Otolaryngology - Head and Neck Surgery ·Christine G. Gourin, Ralph P. Tufano, Arlene A. Forastiere, Wayne M. Koch, Timothy M. Pawlik, Robert E. Bristow	2010	109
10	Ubiquitin Proteasome System Stress Underlies Synergistic Killing of Ovarian Cancer Cells by Bortezomib and a Novel HDAC6 Inhibitor Clinical Cancer Research ·Martina Bazzaro, Zhenhua Lin, Antonio Santillan, Michael K. Lee, Mei‐Cheng Wang, Kwun Chuen Gary Chan, Robert E. Bristow, Ralph Mazitschek, James E. Bradner, Richard B.S. Roden	2008	107
11	Limited utility of conventional criteria for predicting unresectable disease in patients with advanced stage epithelial ovarian cancer Gynecologic Oncology ·Ritu Salani, Allison E. Axtell, M. Gerardi, Christine H. Holschneider, Robert E. Bristow	2008	55
12	Feasibility and economic impact of a clinical pathway for pap test utilization in Gynecologic Oncology practice Gynecologic Oncology ·Antonio Santillan, Burnelle Le, Marianna Zahurak, Teresa Díaz-Montes, Robert Giuntoli, Robert E. Bristow	2008	8
13	Myosin II Co-Chaperone General Cell UNC-45 Overexpression Is Associated with Ovarian Cancer, Rapid Proliferation, and Motility American Journal Of Pathology ·Martina Bazzaro, Antonio Santillan, Zhenhua Lin, V.O. Shulak, Michael K. Lee, Robert E. Bristow, Ie‐Ming Shih, Richard B.S. Roden	2007	33
14	Centralization of care for patients with advanced‐stage ovarian cancer Cancer ·Robert E. Bristow, Antonio Santillan, Teresa Díaz-Montes, Ginger J. Gardner, Robert Giuntoli, 이호백, Kevin D. Frick, Deborah K. Armstrong	2007	55
15	Evaluation and Management of Adnexal Masses During Pregnancy Clinical Obstetrics & Gynecology ·Robert Giuntoli, Russell Vang, Robert E. Bristow	2006	69
16	Combined FDG-positron emission tomography and computed tomography for the detection of ovarian cancer recurrence in an inguinal hernia sac Gynecologic Oncology ·Teresa Díaz-Montes, Heather A. Jacene, Richard L. Wahl, Robert E. Bristow	2005	7
17	Multidetector CT of Peritoneal Carcinomatosis from Ovarian Cancer Radiographics ·Harpreet K. Pannu, Robert E. Bristow, F.J. Montz, Elliot K. Fishman	2003	112
18	Cancer and pregnancy: recent developments Current Opinion in Obstetrics & Gynecology ·Renée M Ward, Robert E. Bristow	2002	13
19	Positron Emission Tomography for Detecting Clinically Occult Surgically Resectable Metastatic Ovarian Cancer Gynecologic Oncology ·Robert E. Bristow, Fiona Simpkins, Harpreet K. Pannu, Elliot K. Fishman, F.J. Montz	2002	25
20	Ovulation induction, infertility, and ovarian cancer risk Fertility and Sterility ·Edward E. Wallach, Robert E. Bristow, Beth Y. Karlan	1996	66

About Robert E. Bristow

Robert E. Bristow is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Surgery, Oncology and Otorhinolaryngology, having authored 313 papers that have together received 15.2k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (201 papers), Endometrial and Cervical Cancer Treatments (114 papers), Intraperitoneal and Appendiceal Malignancies (97 papers), Endometriosis Research and Treatment (33 papers), Uterine Myomas and Treatments (32 papers), Global Cancer Incidence and Screening (22 papers), Economic and Financial Impacts of Cancer (21 papers) and Cervical Cancer and HPV Research (20 papers). The work is most often cited by research in Reproductive Medicine (10.4k citations), Obstetrics and Gynecology (6.3k citations), Surgery (6.5k citations), Oncology (2.9k citations) and Cancer Research (1.3k citations). Robert E. Bristow has collaborated with scholars based in United States, South Korea and United Kingdom. Frequent co-authors include F.J. Montz, Deborah K. Armstrong, Edward L. Trimble, S. Dennis, Rafael S. Tomacruz, Suk‐Joon Chang, Jenny Chang, Robert Giuntoli, Ritu Salani and Antonio Santillan. Their work appears in journals such as Gynecologic Oncology, International Journal of Gynecological Cancer, Journal of Clinical Oncology, Obstetrics and Gynecology and American Journal of Obstetrics and Gynecology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact